Adverse Side Effects of Crizotinib in the Treatment of Anaplastic Lymphoma Kinase-Mutated Non-small Cell Lung Cancer: A Systematic Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adverse Side Effects of Crizotinib in the Treatment of Anaplastic Lymphoma Kinase-Mutated Non-small Cell Lung Cancer: A Systematic Review

Published:2023-09-19 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

George Sherie,Shahi Srushti R,Ali Zahra,Abaza Abdelrahman,Jamil Aneeque,Gutlapalli Sai Dheeraj,Ali Marya,Oble Mrinal J P,Sonia Shamsun Nahar,Hamid Pousette

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference21 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung H;CA Cancer J Clin,2021

2. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment;Duma N;Mayo Clin Proc,2019

3. Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches;Shea M;Ther Adv Respir Dis,2016

4. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study;Camidge DR;Lancet Oncol,2012

5. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas;Paik PK;Cancer,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP